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This appendix has been provided by the authors to give readers additional information about their work.
Supplement to: Di Bisceglie AM, Shiffman ML, Everson GT, et al. Prolonged therapy of advanced chronic hepa-
titis C with low-dose peginterferon. N Engl J Med 2008;359:2429-41.
WEB ONLY Figure  (for on-line publication only).  Forest plot showing the results of a 
post hoc exploratory analysis to examine the heterogeneity of treatment effect according 
to various baseline characteristics.  Note that the lack of treatment effect is consistent 
among all identified subgroups and using several important baseline variables.   
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Hazard Ratio
Study Patients
Virologic Response
Age
Gender
Race/Ethnicity
BMI
Diabetes
Genotype 1
Log HCV RNA
ALT
Total bilirubin
Albumin
Prothrombin
Platelets
Cirrhosis
HAI
Esophageal Varices
Total
Null response
Partial response
Responder
Express
Age < 47
Age 47-53
Age 54+
Male
Female
White
Black
Hispanic
< 26.3
26.3 - 32.6
32.7+
No
Yes
Yes
No
< 6.1
6.1 - 6.7
6.8+
< 60
60-129
130+
< 0.6
0.6 - 0.9
1.0+
< 3.7
3.7 - 4.1
4.2+
< 1.0
1
1.1+
< 116
116 - 204
205+
No
Yes
< 6
6-8
9+
No
Yes
HR < 1 Favors treatment 
